Page last updated: 2024-08-26

combretastatin and triphenylphosphine

combretastatin has been researched along with triphenylphosphine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, T; Chen, Z; Cheng, J; Deng, X; Feng, P; Hou, L; Huang, W; Lai, H; Li, Y; Yang, F; Zhan, Z	1

Other Studies

1 other study(ies) available for combretastatin and triphenylphosphine

Article	Year
The investigation and bioorthogonal anticancer activity enhancement of a triphenylphosphine-labile prodrug of seleno-combretastatin-4. Chemical communications (Cambridge, England), 2020, Nov-19, Volume: 56, Issue:92 Topics: Antineoplastic Agents; Bibenzyls; Cell Membrane Permeability; Dose-Response Relationship, Drug; Drug Liberation; Drug Screening Assays, Antitumor; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Signaling Peptides and Proteins; Organophosphorus Compounds; Organoselenium Compounds; Prodrugs; Vascular Endothelial Growth Factor A	2020

Article

Year

The investigation and bioorthogonal anticancer activity enhancement of a triphenylphosphine-labile prodrug of seleno-combretastatin-4.

Chemical communications (Cambridge, England), 2020, Nov-19, Volume: 56, Issue:92

Topics: Antineoplastic Agents; Bibenzyls; Cell Membrane Permeability; Dose-Response Relationship, Drug; Drug Liberation; Drug Screening Assays, Antitumor; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Signaling Peptides and Proteins; Organophosphorus Compounds; Organoselenium Compounds; Prodrugs; Vascular Endothelial Growth Factor A

2020